NOVA Oncology

NOVA Oncology Cancer Center, On site Laboratory and Infusion Suite, Located in the Heart of Mcallen Medical center welcome patients starting April-15-2025

Hello, My name is Raghad. I'm a cancer doctor and I'm very passionate about what I do. I love science, biology and humans. Oncology makes the best field for me where I practice my skills and provide care for my patients. I have worked for 4 years in oncology drug development in addition to my official fellowship training in hematology and in oncology. This means, I work with patients who needs cli

nical trials. Those patients are very worried and can be very sick from burden of disease or accompanying illness. My goal is treat the patient and try to find a drug ( still in the phase of a trial) to any cancer patient comes to my practice. I work with various sponsors to develop a program in the Detroit Suburbs to patients living in 50-100 miles radius. I believe clinical trials is best delivered in private practice lead by physicians where red tape is minimized so study activation time is vastly shortened. The practice opens November 1st.

05/03/2026

Our site has a trial open for advances stage urinary bladder cancer, this trial offers state of the art drugs and precisely target the driving mutation.
This is provided with all costs of the drugs covered by the study.

05/03/2026

Dr Karim and her team offers a breast cancer clinical trial for patients with hormone receptor disease in the metastatic setting.
We are site #2 to find a patient eligible in the whole United States.
This trial offers state of art targeted therapy and provide access to population of cancer patients that has no access to trials otherwise.
Please call us to inquire 956-234-4400

09/26/2023

Any Patient with should ask their oncologist about their scans and tumor marker if applicable. If disease appears to be progressing, then ask your doctor to look for a phase I trial for you.

https://www.youtube.com/watch?v=vn4eCX1kYXg&t=114sVery interesting technology
09/25/2023

https://www.youtube.com/watch?v=vn4eCX1kYXg&t=114s

Very interesting technology

A hallmark of cancer is the ability to avoid destruction by immune cells. Cancer cells develop escape mechanisms that can render them invisible to the human ...

09/24/2023

the Immunotherapy drug that now has over 18 approvals, was released to the market and became available to cancer patients from the phase I part of testing.



Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) at a dose of 2 mg/kg every three weeks for the treatment of patients with unresectable or metastatic melanoma and disease prog...

09/24/2023

.
Phase I trials provide an excellent option for patients who have no other options.
Contrary to the belief and the historic function of phase I studies as " toxicity studies" recent data suggest that the chances of achieving a response ( shrinkage of overall cancer size by >=30%) is now about 20% and it can even be higher if we choose the right molecular profile to 40%.

We encourage regular oncologist to look for a possible trial for their patients.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868302/

09/24/2023

a drug that target a rare genetic mutation in lung cancer was approved in 2014 from testing it on only 59 patients. It was approved from the phase I stage. Phase I part of drug testing is when the drug is first approved to be tried in human subjects after animal studies.

We want more approvals and more patients participate in those studies.

https://www.nejm.org/doi/full/10.1056/nejmoa1311107

Address

5533 North McColl Road
McAllen, TX
78504

Telephone

+19567771100

Website

Alerts

Be the first to know and let us send you an email when NOVA Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category